These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34086064)

  • 21. Symptom burden of patients with moderate-to-severe atopic dermatitis.
    Egeberg A; Anderson P; Piercy J; Massey L; Cappelleri JC; Encinas GA; Feeney C; Dibonaventura M
    Eur J Dermatol; 2021 Dec; 31(6):752-758. PubMed ID: 34935621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychological assessment of atopic dermatitis in Asia: a systematic review.
    Ishak N; Mukhtar F; Munawar K; Coudhry FR; Roy M; Jalal FA; Choi CS
    Psychol Health Med; 2023 Jan; 28(1):1-26. PubMed ID: 35000520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Health-related quality of life in patients with atopic dermatitis.
    Maksimović N; Janković S; Marinković J; Sekulović LK; Zivković Z; Spirić VT
    J Dermatol; 2012 Jan; 39(1):42-7. PubMed ID: 22044078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quality of Life and Characterization of Patients With Atopic Dermatitis in Portugal: The QUADEP Study.
    Carvalho D; Aguiar P; Mendes-Bastos P; Palma-Carlos A; Freitas J; Ferrinho P
    J Investig Allergol Clin Immunol; 2020; 30(6):430-438. PubMed ID: 31530518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patients' and Caregivers' Experiences With Atopic Dermatitis-Related Burden, Medical Care, and Treatments in 8 Countries.
    Capozza K; Funk M; Hering M; Lang J; Merhand S; Manion R; Orevillo K; Picozza M; Proctor A; Schwennesen T; Begolka WS; Tullos K; Talent C; Tu M; Vastrup AS; Schwartz A
    J Allergy Clin Immunol Pract; 2023 Jan; 11(1):264-273.e1. PubMed ID: 36332836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review.
    Hill MK; Kheirandish Pishkenari A; Braunberger TL; Armstrong AW; Dunnick CA
    J Am Acad Dermatol; 2016 Nov; 75(5):906-917. PubMed ID: 27615798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.
    Schwartzman G; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY; Silverberg JI
    J Am Acad Dermatol; 2021 Sep; 85(3):636-644. PubMed ID: 33484762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes.
    Silverberg JI; Thyssen JP; Simpson EL; Yosipovitch G; Ständer S; Valdez H; Rojo R; Biswas P; Myers DE; Feeney C; DiBonaventura M
    Am J Clin Dermatol; 2021 Jul; 22(4):541-554. PubMed ID: 33954933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement in sleep and itch and enhanced quality of life in adult patients with moderate-to-severe atopic dermatitis: results from a phase 3 trial of baricitinib therapy.
    Lio PA; Simpson EL; Han G; Soung J; Ball S; Sun L; Casillas M; DeLozier AM; Ding Y; Eichenfield LF
    J Dermatolog Treat; 2022 Jun; 33(4):2057-2062. PubMed ID: 34176407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials.
    Reich K; DeLozier AM; Nunes FP; Thyssen JP; Eichenfield LF; Wollenberg A; Ross Terres JA; Watts SD; Chen YF; Simpson EL; Silverberg JI
    J Dermatolog Treat; 2022 May; 33(3):1521-1530. PubMed ID: 33222559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.
    Fasseeh AN; Elezbawy B; Korra N; Tannira M; Dalle H; Aderian S; Abaza S; Kaló Z
    Dermatol Ther (Heidelb); 2022 Dec; 12(12):2653-2668. PubMed ID: 36197589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining the association between pruritus and quality of life in patients with atopic dermatitis treated with crisaborole.
    Ständer S; Yosipovitch G; Bushmakin AG; Cappelleri JC; Luger T; Tom WL; Ports WC; Zielinski MA; Tallman AM; Tan H; Gerber RA
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1742-1746. PubMed ID: 31132182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An audit of the impact of a consultation with a paediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants' Dermatitis Quality of Life Index and Dermatitis Family Impact score.
    Beattie PE; Lewis-Jones MS
    Br J Dermatol; 2006 Dec; 155(6):1249-55. PubMed ID: 17107397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender differences in health-related and family quality of life in young children with atopic dermatitis.
    Chernyshov PV
    Int J Dermatol; 2012 Mar; 51(3):290-4. PubMed ID: 22348564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of Pruritus in Relation to Self-assessed Severity of Atopic Dermatitis.
    Huet F; Faffa MS; Poizeau F; Merhand S; Misery L; Brenaut E
    Acta Derm Venereol; 2019 Mar; 99(3):279-283. PubMed ID: 30264161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dupilumab for children and adolescents with atopic dermatitis: An Asian perspective.
    Chia SY; Wee LWY; Koh MJA
    Dermatol Ther; 2021 May; 34(3):e14933. PubMed ID: 33751751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of pediatric atopic dermatitis on families: A review.
    Yang EJ; Beck KM; Sekhon S; Bhutani T; Koo J
    Pediatr Dermatol; 2019 Jan; 36(1):66-71. PubMed ID: 30556595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study.
    Kim BS; Sun K; Papp K; Venturanza M; Nasir A; Kuligowski ME
    J Am Acad Dermatol; 2020 Jun; 82(6):1305-1313. PubMed ID: 32057960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups.
    Weber MB; Fontes Neto Pde T; Prati C; Soirefman M; Mazzotti NG; Barzenski B; Cestari TF
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):992-7. PubMed ID: 18422535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.